Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2012-A00602-41 | Registry Identifier | RCB |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Class |
|---|---|
| Nantes University Hospital | OTHER |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Sacral nerve stimulation (SNS) is a new therapeutic option to treat fecal incontinence, although its mecanims of action remains poorly understood. The investigators hypothtized that SNS could act on enteric nervous system (ENS). To verify this hypothesis, the investigators will collect biopsy samples from patients implanted for SNS, and assess whether SNS induces changes in ENS.
Sacral nerve stimulation (SNS) is a new therapeutic option to treat fecal incontinence. Its efficacy yields 80% approximately, but its mecanims of action remains poorly understood. In particular, SNS does not restore anal squeezing contraction nor it increase anal tone. Recently, using a porcine model, it was shown that SNS changed colonic permeability, suggesting that SNS may activate the enteric nervous system (ENS).
The investigators hypothtized therefore that SNS could act on enteric nervous system (ENS).
To verify this hypothesis, the investigators will collect biopsy samples from patients before and after implantation for SNS. The investigators will assess whether SNS induces changes in ENS, and if this is correlated to SNS efficacy.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Fecal incontinence | Experimental | Patient with fecal incontinence and referred for a treatment with sacral nerve stimulation |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Sacral nerve stimulation | Procedure | implantation of a stimulation electrode in one of the S2-S3-S4 sacral hole then connected to a subcutaneous stimulator for permanent stimulation of the sacral nerve |
| Measure | Description | Time Frame |
|---|---|---|
| Number of neurons producing vasoactive intestinal peptide (VIP) | Number of neurons producing vasoactive intestinal peptide (VIP) by immunochemistry | 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| Number of cholinergic neurons | Number of cholinergic neurons by immunochemistry | 6 months |
| Measure | Description | Time Frame |
|---|---|---|
| Fecal incontinence score | Measured using the Cleveland Clinic score | 6 months |
| Quality of life | measured using the FIQL score that has been validated in french |
Inclusion Criteria:
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
| Name | Affiliation | Role |
|---|---|---|
| Guillaume Gourcerol, MD, PhD | Rouen University Hospital, France | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Rouen University Hospital | Rouen | Normandy | 76000 | France | ||
| Nantes University Hospital |
Not provided
| ID | Term |
|---|---|
| D005242 | Fecal Incontinence |
| ID | Term |
|---|---|
| D012002 | Rectal Diseases |
| D007410 | Intestinal Diseases |
| D005767 | Gastrointestinal Diseases |
| D004066 | Digestive System Diseases |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| 6 months |
| Nantes |
| Pays de Loire |
| 44000 |
| France |